Valine

CHOP Researchers Find Branched Chain Amino Acid Supplementation May Aid in Concussion Recovery

Retrieved on: 
Tuesday, March 19, 2024
Online, Research, Mind, Stroke, Concussion, Assistant, CHOP, Critical Care Medicine (journal), Patient, DSM-IV codes, Journal, Anesthesiology, Leucine, Dana Foundation, Health, University, Doctor of Philosophy, MD, Human, Valine, Critical care, Adolescence, Isoleucine, Veteran, Clinical trial, BCAA, Pediatrics, Traumatic brain injury, National Institutes of Health, Hospital, Head injury, Randomized controlled trial, Safety, Ageing, HIT, Bangladesh Technical Education Board, Medicine, Children's Hospital of Philadelphia, MSCE, Dietary supplement

PHILADELPHIA, March 19, 2024 /PRNewswire/ -- In the first clinical trial of a targeted pharmacologic therapeutic for mild traumatic brain injury in pediatric patients, scientists from the Minds Matter Concussion Frontier Program at Children's Hospital of Philadelphia (CHOP) have found preliminary evidence that adolescents and young adults with concussion who take a specific formulation of branched chain amino acid (BCAA) supplements after injury experience faster symptom reduction and return to physical activity. The findings were published online by the Journal of Neurotrauma.

Key Points: 
  • The mainstay of treatment remains symptom management with temporary modification of cognitive and physical activity and over the counter medication.
  • Although active rehabilitation strategies have shown promise for improving recovery time, including aerobic, vestibular, and vision interventions, these can be time and labor intensive.
  • To date, no targeted pharmacologic intervention to improve clinical outcomes in concussion has been evaluated in humans.
  • However, prior to this study, no human studies involving adolescents and young adults have assessed the potential benefits of this formulation of BCAAs as a specific treatment to aid in concussion recovery.

Top Shelf Nutrition Gives an Early Sneak Peek at Its BCAA/EAA + Hydration Formula

Retrieved on: 
Thursday, November 2, 2023
Leucine, BCAA, Isoleucine, EAA, Dicarboxylic acid, Valine, Fatigue, Dietary supplement

FORT LAUDERDALE, Fla., Nov. 2, 2023 /PRNewswire/ -- Top Shelf Nutrition is a Florida-based health brand that focuses on providing high-dosage supplements with elite ingredients and transparent labels. The brand already has a quickly-growing catalog that includes plant protein powder, collagen peptides, a thermogenic energy option, immune support, a superfoods blend, and its original flagship pre-workout formula.

Key Points: 
  • The brand already has a quickly-growing catalog that includes plant protein powder, collagen peptides, a thermogenic energy option, immune support, a superfoods blend, and its original flagship pre-workout formula.
  • The latest addition to this all-star supplement lineup is on track to arrive by the new year and is called BCAA/EAA + Hydration.
  • BCAA stands for "branch chain amino acids" and consists of three of the nine essential amino acids: leucine, isoleucine, and valine.
  • Along with generous doses of these two titular ingredients, the BCAA/EAA + Hydration formula includes:

Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise

Retrieved on: 
Monday, October 23, 2023
Colon, Oncolytics Biotech, Genetics, News, Lung, Disease, Risk, Messenger, Lijun International Pharmaceutical (Holding) Co. Ltd., BNTX, Glycine, BioNTech, G12, Hope, RET, Prostate cancer, BRCA2, Cancer, Immune system, Pancreatic cancer, ORR, Hand, University, Roche, Therapy, Patient, Natural history of disease, DNA, CR, Eli Lilly and Company, CAD, 23andMe, JD, OTC, Eli Lilly, FOLFIRINOX, BRCA, Research, Clinical trial, BBB National Programs, Survival rate, Aspartic acid, Valine, Woman, ONC, MD Anderson Cancer Center, TSX, PCCP, Survival, FDA, Lilly, Attention, AACR, Incidence, BRCA1, New View (Eleanor Friedberger album), MBA, KRAS, Entrepreneurship, Breast, Diagnosis, Prostate, FTD, Pharmaceutical industry, Medical imaging, Vaccine, Nature

VANCOUVER, BC, Oct. 23, 2023 /PRNewswire/ -- USA News Group - Despite being a relatively rare form of cancer, pancreatic cancer remains one of the deadliest in the oncology field, the third leading cause of cancer death in the USA. Still not fully understood, pancreatic cancer's 5-year survival rate is currently only 12%. New analysis of data from the National Program of Cancer Registries database, covering around 65% of the US population, suggests that the incidence of pancreatic cancer among individuals younger than 55 years is increasing more rapidly than in those 55 years or older, and also more quickly in women than in men. As more and more cases of young people are showing up, calls from the leading pancreatic cancer organization PanCAN to increase funding for research are getting louder. Thankfully, within the biotech sector, there have been plenty of developments giving hope in the fight against pancreatic cancer, including those from Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), Eli Lilly and Company, Roche Holding AG (OTC:RHHBY), BioNTech SE (NASDAQ:BNTX), and even 23andMe Holding Co (NASDAQ:ME).

Key Points: 
  • As more and more cases of young people are showing up, calls from the leading pancreatic cancer organization PanCAN to increase funding for research are getting louder .
  • "By teaming up with PanCAN, we believe we may be able to expedite development and provide pancreatic cancer patients with a bespoke immunotherapeutic treatment option."
  • The BRCA1 and BRCA2 variants may also be associated with an increased risk for prostate cancer, pancreatic cancer, and potentially other cancers.
  • "It's an important milestone that shows we're headed in the right direction – and this means so much to all those affected by pancreatic cancer."

Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise

Retrieved on: 
Monday, October 23, 2023
Colon, Oncolytics Biotech, Genetics, News, Lung, Disease, Risk, Messenger, Lijun International Pharmaceutical (Holding) Co. Ltd., BNTX, Glycine, BioNTech, G12, Hope, RET, Prostate cancer, BRCA2, Cancer, Immune system, Pancreatic cancer, ORR, Hand, University, Roche, Therapy, Patient, Natural history of disease, DNA, CR, Eli Lilly and Company, CAD, 23andMe, JD, OTC, Eli Lilly, FOLFIRINOX, BRCA, Research, Clinical trial, BBB National Programs, Survival rate, Aspartic acid, Valine, Woman, ONC, MD Anderson Cancer Center, TSX, PCCP, Survival, FDA, Lilly, Attention, AACR, Incidence, BRCA1, New View (Eleanor Friedberger album), MBA, KRAS, Entrepreneurship, Breast, Diagnosis, Prostate, FTD, Pharmaceutical industry, Medical imaging, Vaccine, Nature

VANCOUVER, BC, Oct. 23, 2023 /PRNewswire/ -- USA News Group - Despite being a relatively rare form of cancer, pancreatic cancer remains one of the deadliest in the oncology field, the third leading cause of cancer death in the USA. Still not fully understood, pancreatic cancer's 5-year survival rate is currently only 12%. New analysis of data from the National Program of Cancer Registries database, covering around 65% of the US population, suggests that the incidence of pancreatic cancer among individuals younger than 55 years is increasing more rapidly than in those 55 years or older, and also more quickly in women than in men. As more and more cases of young people are showing up, calls from the leading pancreatic cancer organization PanCAN to increase funding for research are getting louder. Thankfully, within the biotech sector, there have been plenty of developments giving hope in the fight against pancreatic cancer, including those from Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), Eli Lilly and Company, Roche Holding AG (OTC:RHHBY), BioNTech SE (NASDAQ:BNTX), and even 23andMe Holding Co (NASDAQ:ME).

Key Points: 
  • As more and more cases of young people are showing up, calls from the leading pancreatic cancer organization PanCAN to increase funding for research are getting louder .
  • "By teaming up with PanCAN, we believe we may be able to expedite development and provide pancreatic cancer patients with a bespoke immunotherapeutic treatment option."
  • The BRCA1 and BRCA2 variants may also be associated with an increased risk for prostate cancer, pancreatic cancer, and potentially other cancers.
  • "It's an important milestone that shows we're headed in the right direction – and this means so much to all those affected by pancreatic cancer."

Hemp, Inc. Reports: Growing Legalization of Industrial Hemp Driving Global Demand for Hemp

Retrieved on: 
Thursday, September 28, 2023
CBDA, Valine, Food, Diet, Methionine, Lysine, Seed, Paint, Leucine, Threonine, Clothing, Cannabinoid, Absorption, Dicarboxylic acid, CBG, Phenylalanine, CBN, Tryptophan, Plant, Investment, OTC, Histidine, Coffee, Paper, Health, Textile, CBGA, Isoleucine, Rest, Dietary supplement, Hemp, CBD

LAS VEGAS, NV, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hemp, Inc. (OTC PINK: HEMP) is perfectly positioned at the forefront of the industrial hemp industry as demand increases and opportunities abound.

Key Points: 
  • LAS VEGAS, NV, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hemp, Inc. (OTC PINK: HEMP) is perfectly positioned at the forefront of the industrial hemp industry as demand increases and opportunities abound.
  • The recent release of a comprehensive research report, Global Industrial Hemp Market (2023-2031) , says the global industrial hemp market is forecast to grow to $134.6 billion by 2030.
  • As one of the most rapidly growing plants on the planet, hemp is used to make a variety of products.
  • With the “growing legalization of industrial hemp farming around the world, the demand for industrial hemp has been exponential.

ZXCHEM USA presents Revolutionary New Manufacturing Process for Plant Proteins in the US and Canadian Markets

Retrieved on: 
Wednesday, September 6, 2023
Valine, RTD, Food, Methionine, Lysine, Ice cream, Leucine, Enzyme, Threonine, Nutrient, Cheese, Multimedia, Dicarboxylic acid, Phenylalanine, Economic methodology, Milk, Tryptophan, Protein, Pesticide, PDCAAS, Water, Yogurt, Pea protein, Spray drying, Histidine, Protein Digestibility Corrected Amino Acid Score, Isoleucine, Fine chemical, Dairy, Dietary supplement

We are excited to offer them in the US and Canadian markets for the first time," says Wade Zheng, President of ZXCHEM USA.

Key Points: 
  • We are excited to offer them in the US and Canadian markets for the first time," says Wade Zheng, President of ZXCHEM USA.
  • HydroRice™ PA80 is 100% rice protein while HydroPR™ 80 is a 40/60 blend of rice and pea protein.
  • Both products are manufactured with a revolutionary new process that does not use enzymes or hydrolyzation to change the protein functionality.
  • Anhui Shunxin has assigned ZXCHEM USA as the exclusive distributor for the US and Canadian markets.

Angel Yeast Highlights Sustainable Protein and Natural Taste Solutions at IFT FIRST 2023

Retrieved on: 
Thursday, July 20, 2023
Tao, Valine, Mineral, Diet, Food technology, Exhibition, Snack, Biotechnology, GMO, Nutrient, Fermentation, Multimedia, Dietary fiber, Food, GM, Institute of Food Technologists, Meat, Beer, Dietary supplement

CHICAGO, July 20, 2023 /PRNewswire/ -- Angel Yeast (SHA:600298), a premier global yeast company, showcased its sustainable yeast protein and compound seasoning solutions at the annual expo of the Institute of Food Technologists ("IFT FIRST 2023"), in Chicago, that took place between July 16 and 19.

Key Points: 
  • CHICAGO, July 20, 2023 /PRNewswire/ -- Angel Yeast (SHA:600298), a premier global yeast company, showcased its sustainable yeast protein and compound seasoning solutions at the annual expo of the Institute of Food Technologists ("IFT FIRST 2023"), in Chicago, that took place between July 16 and 19.
  • "Compared to plant-based and animal proteins, natural yeast protein is a more sustainable, environmental-friendly, gluten-free, No-GMO and nutritious food substance.
  • The versatile yeast as a natural ingredient will be crucial to developing novel products, and Angel Yeast is capturing the market trends to deliver products that best suit the needs of global customers", said Hang Tao, GM of Angel Yeast North America Branch.
  • Angel Yeast has pioneered Angel Taste Solutions that build exciting flavors, as well as fermentation nutrients for food ingredients, probiotics fermentation and food culture.

Angel Yeast Highlights Sustainable Protein and Natural Taste Solutions at IFT FIRST 2023

Retrieved on: 
Thursday, July 20, 2023
Tao, Valine, Mineral, Diet, Food technology, Exhibition, Snack, Biotechnology, GMO, Nutrient, Fermentation, Dietary fiber, Food, GM, Institute of Food Technologists, Meat, Beer, Dietary supplement

CHICAGO, July 20, 2023 /PRNewswire/ -- Angel Yeast (SHA:600298), a premier global yeast company, showcased its sustainable yeast protein and compound seasoning solutions at the annual expo of the Institute of Food Technologists ("IFT FIRST 2023"), in Chicago, that took place between July 16 and 19.

Key Points: 
  • CHICAGO, July 20, 2023 /PRNewswire/ -- Angel Yeast (SHA:600298), a premier global yeast company, showcased its sustainable yeast protein and compound seasoning solutions at the annual expo of the Institute of Food Technologists ("IFT FIRST 2023"), in Chicago, that took place between July 16 and 19.
  • "Compared to plant-based and animal proteins, natural yeast protein is a more sustainable, environmental-friendly, gluten-free, No-GMO and nutritious food substance.
  • Angel Yeast has pioneered Angel Taste Solutions that build exciting flavors, as well as fermentation nutrients for food ingredients, probiotics fermentation and food culture.
  • Angel Yeast leverages yeast and biotechnology to revolutionize dietary habits, food production, and environmental interplay, with the ultimate goal of enhancing life quality and conserving our planet for the benefit of future generations.

Dandelions are a lifeline for bees on the brink – we should learn to love them

Retrieved on: 
Friday, April 28, 2023
Hatred, Valine, Food, Diet, Bee, Vanilla, Garden, Flower, Pollen, Plantlife, Research, Element, Science, Plant, Pesticide, Soil, Herbicide, Love, Sustenance, City, Environment, Isoleucine, Farm, Natural rubber, Agriculture, Animal husbandry

Dandelions, love them or hate them, are blooming in abundance all over the UK this spring.

Key Points: 
  • Dandelions, love them or hate them, are blooming in abundance all over the UK this spring.
  • As an ecologist who studies the insects which visit these flowers, so redolent of sunshine, I have never been able to understand why anyone might hate them.

Flowers in the city

    • What makes dandelions so successful in feeding a wide variety of pollinators is the shape of their flowers.
    • The evolution of bees is a dance between the changing shapes of flowers and the corresponding length of bee tongues.
    • Complicated flowers, like vanilla, evolved to make sure only a certain bee species could pollinate them, whereas others have evolved simple, open flowers that anyone can get pollen and nectar from.
    • Take a look at a patch of dandelion flowers and you’ll be amazed at the diversity of visitors.
    • A diet lacking in these elements can hamper a bee’s ability to grow, resist disease and raise its young.

Dandelion dawn

    • Sadly, at the end of May, all that lovely wildflower habitat could be cut down and sprayed with herbicides.
    • Manicured lawns are essentially green deserts: ostensibly full of plants but with nothing to nourish bees or other wildlife.
    • The next time you see a dandelion, try to see it as a bee would.

Provectus Algae Receives Strategic Investment from Biotech Leader CJ Bio

Retrieved on: 
Wednesday, March 1, 2023
Chemicals, Plastics, Retail, Green Technology, Manufacturing, Sustainability, Professional Services, Environment, Venture Capital, Fitness & Nutrition, Agriculture, Natural Resources, Other Manufacturing, Biotechnology, Food, Beverage, Health, CJ CheilJedang, CJ, Partnership, Valine, Investment, Tryptophan, SPC, Synthetic biology, Plant, Fine chemical

Provectus Algae (Provectus) has secured an undisclosed strategic investment from CJ BIO , a division of South Korea-based food & bio company CJ CheilJedang.

Key Points: 
  • Provectus Algae (Provectus) has secured an undisclosed strategic investment from CJ BIO , a division of South Korea-based food & bio company CJ CheilJedang.
  • This strategic investment provides Provectus Algae with additional funds to accelerate commercialization efforts that bring innovative specialty ingredients to market, and Provectus Algae expects to gain access to the experience and expertise CJ BIO has built in the biomanufacturing sector.
  • “As a world leader in commercial biotechnologies, CJ BIO brings a wealth of valuable insight to our operations.
  • CJ BIO continues to make substantial investments into innovative technologies, like that of Provectus Algae, to help the field of green biotechnology continue to blossom.